119 related articles for article (PubMed ID: 38803127)
1. Evaluation of telemedicine medical abortion using a no-test protocol in the Eastern Europe and Central Asian region: Evidence from Ukraine, Uzbekistan, and Azerbaijan.
Tsereteli T; Platais I; Maru M; Maystruk G; Kurbanbekova D; Rzayeva G; Winikoff B
Int J Gynaecol Obstet; 2024 May; ():. PubMed ID: 38803127
[TBL] [Abstract][Full Text] [Related]
2. Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.
Platais I; Tsereteli T; Comendant R; Kurbanbekova D; Winikoff B
Contraception; 2015 Feb; 91(2):178-83. PubMed ID: 25497383
[TBL] [Abstract][Full Text] [Related]
3. Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits.
Tsereteli N; Mamatsashvili L; Tsertsvadze G; Tsereteli T; Platais I
Eur J Contracept Reprod Health Care; 2023 Apr; 28(2):141-146. PubMed ID: 36751958
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
[TBL] [Abstract][Full Text] [Related]
5. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
[TBL] [Abstract][Full Text] [Related]
6. Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study.
Peña M; Figueroa Flores K; Muñoz Ponce M; Facio Serafín D; Camarillo Zavala AM; Ruiz Cruz C; Ortiz Salgado IG; Ochoa Rosado Y; Socarras T; Pacheco López A; Bousiéguez M
Contraception; 2022 Oct; 114():67-73. PubMed ID: 35753406
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine.
Platais I; Tsereteli T; Maystruk G; Kurbanbekova D; Winikoff B
BMJ Sex Reprod Health; 2019 Jun; ():. PubMed ID: 31164394
[TBL] [Abstract][Full Text] [Related]
9. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
Chong E; Shochet T; Raymond E; Platais I; Anger HA; Raidoo S; Soon R; Grant MS; Haskell S; Tocce K; Baldwin MK; Boraas CM; Bednarek PH; Banks J; Coplon L; Thompson F; Priegue E; Winikoff B
Contraception; 2021 Jul; 104(1):43-48. PubMed ID: 33781762
[TBL] [Abstract][Full Text] [Related]
10. Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
Meurice ME; Whitehouse KC; Blaylock R; Chang JJ; Lohr PA
Contraception; 2021 Jul; 104(1):61-66. PubMed ID: 33974918
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trials.
Raghavan S; Maistruk G; Shochet T; Bannikov V; Posohova S; Zhuk S; Lishchuk V; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):112-9. PubMed ID: 23465062
[TBL] [Abstract][Full Text] [Related]
12. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.
Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
BMJ Sex Reprod Health; 2021 Oct; 47(4):246-251. PubMed ID: 33542062
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.
Aiken A; Lohr PA; Lord J; Ghosh N; Starling J
BJOG; 2021 Aug; 128(9):1464-1474. PubMed ID: 33605016
[TBL] [Abstract][Full Text] [Related]
17. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
[TBL] [Abstract][Full Text] [Related]
18. A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
Endler M; Petro G; Gemzell Danielsson K; Grossman D; Gomperts R; Weinryb M; Constant D
Lancet; 2022 Aug; 400(10353):670-679. PubMed ID: 36030811
[TBL] [Abstract][Full Text] [Related]
19. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.
Chong E; Frye LJ; Castle J; Dean G; Kuehl L; Winikoff B
Contraception; 2015 Sep; 92(3):215-9. PubMed ID: 26142620
[TBL] [Abstract][Full Text] [Related]
20. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
Contraception; 2023 May; 121():109962. PubMed ID: 36736715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
